Sponsor Pipeline

CASI pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-23 NCT07641426
A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and…		 Recruitment opened
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07017725 A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and… Chronic Immune Thrombocytopenia Recruiting
NCT07641426 A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and… Antibody Mediated Rejection Recruiting
Get alerts when CASI pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free